Literature DB >> 24294978

NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia.

Dong-Hee Choi1, Kyoung-Hee Lee, Ji-Hye Kim, Ju-Ha Seo, Hahn Young Kim, Chan Young Shin, Jung-Soo Han, Seol-Heui Han, Yoon-Seong Kim, Jongmin Lee.   

Abstract

AIMS: Chronic cerebral hypoperfusion (CCH) is a common pathological factor that contributes to neurodegenerative diseases such as vascular dementia (VaD). Although oxidative stress has been strongly implicated in the pathogenesis of VaD, the molecular mechanism underlying the selective vulnerability of hippocampal neurons to oxidative damage remains unknown. We assessed whether the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) complex, a specialized superoxide generation system, plays a role in VaD by permanent ligation of bilateral common carotid arteries in rats.
RESULTS: Male Wistar rats (10 weeks of age) were subjected to bilateral occlusion of the common carotid arteries (two-vessel occlusion [2VO]). Nox1 expression gradually increased in hippocampal neurons, starting at 1 week after 2VO and for approximately 15 weeks after 2VO. The levels of superoxide, DNA oxidation, and neuronal death in the CA1 subfield of the hippocampus, as well as consequential cognitive impairment, were increased in 2VO rats. Both inhibition of Nox by apocynin, a putative Nox inhibitor, and adeno-associated virus-mediated Nox1 knockdown significantly reduced 2VO-induced reactive oxygen species generation, oxidative DNA damage, hippocampal neuronal degeneration, and cognitive impairment. INNOVATION AND
CONCLUSION: We provided evidence that neuronal Nox1 is activated in the hippocampus under CCH, causing oxidative stress and consequential hippocampal neuronal death and cognitive impairment. This evidence implies that Nox1-mediated oxidative stress plays an important role in neuronal cell death and cognitive dysfunction in VaD. Nox1 may serve as a potential therapeutic target for VaD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24294978      PMCID: PMC4086030          DOI: 10.1089/ars.2012.5129

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  77 in total

1.  Neurocognitive improvement after carotid artery stenting in patients with chronic internal carotid artery occlusion and cerebral ischemia.

Authors:  Mao-Shin Lin; Ming-Jang Chiu; Yen-Wen Wu; Ching-Chang Huang; Chi-Chao Chao; Ying-Hsien Chen; Hung-Ju Lin; Hung-Yuan Li; Ya-Fang Chen; Lung-Chun Lin; Yen-Bin Liu; Chia-Lun Chao; Wen-Yih Isaac Tseng; Ming-Fong Chen; Hsien-Li Kao
Journal:  Stroke       Date:  2011-08-11       Impact factor: 7.914

Review 2.  Experimental basis of multi-infarct dementia: memory impairments in rodent models of ischemia.

Authors:  H Naritomi
Journal:  Alzheimer Dis Assoc Disord       Date:  1991       Impact factor: 2.703

3.  Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain.

Authors:  Myeung Ju Kim; Kyung-Sue Shin; Young-Bae Chung; Kee Wook Jung; Choong Ik Cha; Dong Hoon Shin
Journal:  Brain Res       Date:  2005-04-08       Impact factor: 3.252

4.  Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity.

Authors:  Hyung-Jin Kim; Jeong-Han Lee; Se-Jin Kim; Gi Su Oh; Hae-Dalma Moon; Kang-Beom Kwon; Channy Park; Byung Hyun Park; Ho-Kyun Lee; Sang-Young Chung; Raekil Park; Hong-Seob So
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

5.  Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II.

Authors:  Shoji Kimura; Guo-Xing Zhang; Akira Nishiyama; Takatomi Shokoji; Li Yao; Yu-Yan Fan; Matlubur Rahman; Takeo Suzuki; Hajime Maeta; Youichi Abe
Journal:  Hypertension       Date:  2005-04-11       Impact factor: 10.190

6.  Cell transformation by the superoxide-generating oxidase Mox1.

Authors:  Y A Suh; R S Arnold; B Lassegue; J Shi; X Xu; D Sorescu; A B Chung; K K Griendling; J D Lambeth
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

Review 7.  Novel isoforms of NADPH-oxidase in cerebral vascular control.

Authors:  Alyson A Miller; Grant R Drummond; Christopher G Sobey
Journal:  Pharmacol Ther       Date:  2006-04-17       Impact factor: 12.310

8.  Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus.

Authors:  Qun Wang; Kenneth D Tompkins; Agnes Simonyi; Ronald J Korthuis; Albert Y Sun; Grace Y Sun
Journal:  Brain Res       Date:  2006-05-02       Impact factor: 3.252

9.  NADPH oxidase immunoreactivity in the mouse brain.

Authors:  Faridis Serrano; Nutan S Kolluri; Frans B Wientjes; J Patrick Card; Eric Klann
Journal:  Brain Res       Date:  2003-10-24       Impact factor: 3.252

Review 10.  Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.

Authors:  Gjumrakch Aliev; Mark A Smith; Mark E Obrenovich; Jack C de la Torre; George Perry
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

View more
  34 in total

Review 1.  Emerging molecular mechanisms of vascular dementia.

Authors:  Milagros C Romay; Camilo Toro; M Luisa Iruela-Arispe
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

2.  Oxidative stress contributes to cerebral metabolomic profile changes in animal model of blast-induced traumatic brain injury.

Authors:  Poonam Rana; Kakulavarapu V Rama Rao; Arunreddy Ravula; Richa Trivedi; Maria D'Souza; Ajay K Singh; Raj K Gupta; Namas Chandra
Journal:  Metabolomics       Date:  2020-03-12       Impact factor: 4.290

3.  Olfactory ensheathing cells transplantation attenuates chronic cerebral hypoperfusion induced cognitive dysfunction and brain damages by activating Nrf2/HO-1 signaling pathway.

Authors:  Ailing Yu; Leilei Mao; Fangfang Zhao; Baoliang Sun
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

4.  Erythropoietin Rescues Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via the EPO-R/JAK2/STAT5/PI3K/Akt/GSK-3β Pathway.

Authors:  Shengli Ma; Juwu Chen; Chen Chen; Na Wei; Jingjing Xu; Guohui Yang; Nan Wang; Yu Meng; Jia Ren; Zongchao Xu
Journal:  Mol Neurobiol       Date:  2017-05-09       Impact factor: 5.590

5.  Betulinic Acid Induces Apoptosis in Differentiated PC12 Cells Via ROS-Mediated Mitochondrial Pathway.

Authors:  Xi Wang; Xiaocheng Lu; Ronglan Zhu; Kaixin Zhang; Shuai Li; Zhongjun Chen; Lixin Li
Journal:  Neurochem Res       Date:  2017-01-25       Impact factor: 3.996

6.  Acupuncture inhibits TXNIP-associated oxidative stress and inflammation to attenuate cognitive impairment in vascular dementia rats.

Authors:  Si-Qi Du; Xue-Rui Wang; Wen Zhu; Yang Ye; Jing-Wen Yang; Si-Ming Ma; Cai-Shuo Ji; Cun-Zhi Liu
Journal:  CNS Neurosci Ther       Date:  2017-11-06       Impact factor: 5.243

Review 7.  Molecular Mechanisms of Vascular Dementia: What Can Be Learned from Animal Models of Chronic Cerebral Hypoperfusion?

Authors:  Si-Qi Du; Xue-Rui Wang; Ling-Yong Xiao; Jian-Feng Tu; Wen Zhu; Tian He; Cun-Zhi Liu
Journal:  Mol Neurobiol       Date:  2016-05-20       Impact factor: 5.590

8.  Inhibiting NADPH oxidase protects against long-term memory impairment induced by neonatal sevoflurane exposure in mice.

Authors:  Z Sun; M Satomoto; Y U Adachi; H Kinoshita; K Makita
Journal:  Br J Anaesth       Date:  2016-05-04       Impact factor: 9.166

Review 9.  Central Nervous System Injury and Nicotinamide Adenine Dinucleotide Phosphate Oxidase: Oxidative Stress and Therapeutic Targets.

Authors:  Ramona E von Leden; Young J Yauger; Guzal Khayrullina; Kimberly R Byrnes
Journal:  J Neurotrauma       Date:  2016-06-27       Impact factor: 5.269

10.  Prevention of Hippocampal Neuronal Damage and Cognitive Function Deficits in Vascular Dementia by Dextromethorphan.

Authors:  Xiaofeng Xu; Bin Zhang; Kaili Lu; Jiangshan Deng; Fei Zhao; Bing-Qiao Zhao; Yuwu Zhao
Journal:  Mol Neurobiol       Date:  2016-02-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.